Table 1 Clinical characteristics of patients with community acquired pneumonia.
From: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia
Cohort1 (n = 127) | Cohort2 (n = 125) | p-value | |
|---|---|---|---|
Sex, M/F | 77/50 | 77/48 | 0.898 |
Age, years | 73.0 (21–99) | 76.0 (31–93) | 0.006 |
Comorbidities | |||
Congestive heart failure (n, %) | 23 (18.1) | 15 (12.0) | 0.218 |
Chronic pulmonary disease (n, %) | 47 (37.3) | 66 (52.8) | 0.016 |
Renal disease (n, %) | 4 (3.1) | 17 (13.6) | 0.003 |
Diabetes mellitus (n, %) | 11 (8.7) | 33 (26.4) | <0.001 |
Chronic liver disease (n, %) | 5 (3.9) | 11 (8.8) | 0.128 |
Cerebrovascular disease (n, %) | 23 (18.1) | 11 (8.8) | 0.042 |
Neoplastic disease (n, %) | 12 (9.4) | 38 (30.4) | <0.001 |
Immunosuppressive agents (n, %) | 7 (5.6) | 33 (26.4) | <0.001 |
Clinical characteristics | |||
Body temperature, | 37.8 (35.0–40.8) | 37.8 (35.6–40.3) | 0.462 |
Systolic blood pressure <90 mmHg (n, %) | 7 (5.5) | 7 (5.6) | 1.000 |
Confusion (n, %) | 24 (19.0) | 12 (9.6) | 0.047 |
Respiratory Failure (SaO2 < 90%) (n, %) | 64 (50.8) | 74 (59.2) | 0.205 |
PaO2/FiO2 ratio | 291.00 (49.8–428.60) | 260.95 (42.1–496.43) | 0.006 |
Laboratory findings | |||
BUN (mg/dL) | 16.70 (4.5–206.0) | 20.00 (7.3–172.5) | 0.008 |
Cre (mg/dl) | 0.75 (0.23–6.69) | 0.87 (0.38–10.60) | 0.003 |
Alb (g/dl) | 3.50 (2.30–5.00) | 3.10 (1.80–4.50) | <0.001 |
WBC (/μL) | 10760 (2300–37000) | 10170 (1000–29330) | 0.932 |
CRP (mg/dl) | 12.00 (0.17–57.65) | 12.04 (0.09–50.17) | 0.886 |
PCT (ng/ml) | ND | 0.68 (0.02–87.8) | NA |
Bacteremia | 8 (6.3) | 7 (5.6) | 0.136 |
